Posted by Michael Wonder on 05 Sep 2023
SK Bioscience withdraws conditional marketing authorisation for COVID-19 vaccine in EU
4 September 2023 - SK Bioscience said it has voluntarily withdrawn its application for a conditional marketing authorisation license to the EMA for SKYCovion, the country's first locally developed COVID-19 vaccine.
The withdrawal comes after one year and one month since the company submitted the conditional marketing authorisation application on 30 July last year.
